FT Health Discusses Cancer, Features Interview With Hugh Pullen Of European Medicines Verification Organisation
FT Health: Combating cancer; Brexit and E.U. medicine verification
The latest issue of the Financial Times’ weekly global health newsletter discusses efforts to address cancer, the world’s second leading cause of death, and features an interview with Hugh Pullen, president of the European Medicines Verification Organisation, discussing the launch of its new system involving the whole medical supply chain across Europe. The newsletter also provides a round-up of global health-related news stories (Dodd, 2/8).